Right ventricular perforation with cardiac tamponade associated with use of a temporary pacing wire and abciximab during complex coronary angioplasty

G Nashed; B French; D Gallagher; A Hopkins; C Juergens; D Leung; H C Lowe

doi:10.1002/(sici)1522-726x(199912)48:4<388::aid-ccd14>3.0.co;2-k

Right ventricular perforation with cardiac tamponade associated with use of a temporary pacing wire and abciximab during complex coronary angioplasty

Catheter Cardiovasc Interv. 1999 Dec;48(4):388-9. doi: 10.1002/(sici)1522-726x(199912)48:4<388::aid-ccd14>3.0.co;2-k.

Authors

G Nashed¹, B French, D Gallagher, A Hopkins, C Juergens, D Leung, H C Lowe

Affiliation

¹ Department of Cardiology, Liverpool Hospital, Sydney, Australia.

PMID: 10559821
DOI: 10.1002/(sici)1522-726x(199912)48:4<388::aid-ccd14>3.0.co;2-k

Abstract

We describe our recent experience of right ventricular perforation leading to cardiac tamponade associated with a complex coronary angioplasty in which abciximab and a temporary pacing wire were used. This is to highlight the possibility that the combined use of temporary pacing wires and the IIb/IIIa receptor antagonists may be associated with an increased risk of this serious complication. Cathet. Cardiovasc. Intervent. 48:388-389, 1999.

MeSH terms

Abciximab
Aged
Angina, Unstable / therapy*
Angioplasty, Balloon, Coronary*
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal / therapeutic use
Cardiac Pacing, Artificial / adverse effects*
Cardiac Tamponade / etiology*
Female
Heart Ventricles / injuries*
Humans
Immunoglobulin Fab Fragments / adverse effects*
Immunoglobulin Fab Fragments / therapeutic use
Platelet Aggregation Inhibitors / adverse effects*
Platelet Aggregation Inhibitors / therapeutic use

Substances

Antibodies, Monoclonal
Immunoglobulin Fab Fragments
Platelet Aggregation Inhibitors
Abciximab